Infectious Agents and Cancer is affiliated with the African Organisation for Research & Training In Cancer (AORTIC)
Articles
Page 17 of 21
-
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A85
-
The HIV nef protein within ARL is genetically and structurally distinct from those in the brain of patients with HAD
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A77 -
Role of TP53 polymorphisms in sub-Saharan mucosal cancers
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A73 -
Relationship between salivary shedding and seropositivity for Kaposi’s sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV) among South African children and adults: insights on why EBV infection is ubiquitous and KSHV is not
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A69 -
Progression of cervical neoplasia in HIV-seropositive women with and without antiretroviral therapy in Johannesburg, South Africa
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A67 -
Preventing HHV-8 transmission and Kaposi’s sarcoma (KS) risk prediction and prognostication in resource-poor countries
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A66 -
Prevalence of HIV-associated malignancies among PLWHAs accessing HIV services in Abia State, Nigeria
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A65 -
Prevalence of HIV among general surgical patients in southeastern Nigeria
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A64 -
Phase IIA trial of 1% topical cidofovir for treatment of high-grade perianal squamous intraepithelial neoplasia in HIV-infected men and women (AMC046)
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A60 -
Nonlinear Burkitt lymphoma risk patterns with age and CD4 lymphocyte count among persons with AIDS in the United States
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A58 -
Non-AIDS-defining cancer mortality among people with AIDS in Italy
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A57 -
Mortality after cancer diagnosis among HIV-infected individuals in the CFAR Network of Integrated Clinical Systems (CNICS)
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A56 -
MicroRNA analysis in human papillomavirus (HPV)-associated cervical neoplasia and cancer
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A55 -
Malignant lymphoma subgroups from Zaria, Nigeria, reveal absence of HIV/AIDS-related plasmablastic lymphomas and HHV-8-related lymphoproliferative disorders
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A54 -
Malignancies in HIV
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A52 -
KSHV interaction with Langerhans and dermal dendritic cells through C-type lectins
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A48 -
Kaposi’s sarcoma-associated herpesvirus ORF57 promotes escape of viral and human IL6 RNAs from microRNA-mediated suppression
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A45 -
Kaposi’s sarcoma-associated herpesvirus (KSHV) serum DNA not associated with subsequent non-Hodgkin’s lymphoma (NHL) risk
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A44 -
Kaposi sarcoma in South African children
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A43 -
Inhibition of KSHV-associated lymphoma engraftment in SCID mouse by morpholino oligomers
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A40 -
Immunohistochemically confirmed HHV-8-related lymphoproliferative disorders in Uganda
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A39 -
Immunoglobulin abnormalities and monoclonal gammopathy of undetermined significance in uninfected and HIV-infected men
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A38 -
HIV-associated salivary gland disease: a role for BK birus
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A33 -
High acceptance rate of anal pap screening despite limited knowledge about anal dysplasia among HIV+ MSM
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A31 -
HAART and response to therapy improve quality of life (QOL) of African patients with advanced HIV-associated Kaposi’s sarcoma (HIV-KS): a prospective analysis of QOL in the KAART trial
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A30 -
Gamma-tubulin and 53BP1 as candidate biomarkers of human papillomavirus-associated anal dysplasia
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A29 -
Epstein-Barr virus (EBV)-associated miRNAs are important for the maintenance of EBV transformed B cells
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A28 -
Epigenetic deregulation of IGF2 and cervical cancer precursors in HIV+ and HIV- patients
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A27 -
Elevated serum levels of CXCL13 precede HIV-associated non-Hodgkin’s lymphoma
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A24 -
EBV-induced miR-34a functions to stimulate transformed B cell growth
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A23 -
Do people with AIDS develop cancer at younger ages than the general population?
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A22 -
DNA ploidy, cell proliferation, and HIV/EBV association in Tanzanian malignant lymphomas
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A21 -
Distinct profiles of antibodies to Kaposi sarcoma-associated herpesvirus antigens in patients with Kaposi sarcoma, multicentric Castleman’s disease, and primary effusion lymphoma
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A20 -
Diagnosis of HIV-related malignancies in resource-constrained settings of sub-Saharan Africa, a cautionary tale for non-Hodgkin’s lymphoma
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A19 -
Development of a proteomic platform for EBV and KSHV serological screening
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A18 -
Detection and quantitation of HPV in anogenital and oral tissues and fluids of HIV-positive individuals by real-time PCR
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A17 -
Delay in anal cancer diagnosis as a non-AIDS-defining malignancy
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A16 -
Cytosine methylation in the HPV16 3’ L1/ 5’LCR region characterized from anal epithelia of HPV-HIV coinfected men
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A15 -
Cutaneous squamous cell carcinoma in HIV-infected patients: a report of two (2) cases
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A14 -
Current epidemiology of KSHV infection in American men who have sex with men
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A13 -
Characterization of lytic human herpesvirus-8 gene expression in Kaposi sarcoma tumor tissue and its clinical correlates
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A11 -
Cervical cancer epidemiology among HIV-infected women in North America
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A9 -
C/EBPbeta mediates bortezomib-induced EBV and KSHV lytic gene expression
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A8 -
Bim nuclear translocation and inactivation by HHV-8 interferon regulatory factor 1
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A7 -
Bacteria-mediated reactivation of gammaherpesviruses
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A6 -
Attitude of health care providers in Abia State, Nigeria, to people living with HIV and AIDS
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A5 -
An ATM/Chk2-mediated DNA damage responsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cells
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A4 -
AIDS-related lymphomas in Nigeria an emerging phenomenon
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A3 -
AIDS-related Kaposi’s sarcoma: outcomes after initiation of highly active antiretroviral therapy under routine conditions in Zimbabwe
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A2 -
A higher proportion of squamous intraepithelial lesion of the cervix in symptomatic HIV-infected women at a tertiary health center in Tanzania
Citation: Infectious Agents and Cancer 2010 5(Suppl 1):A1
-
Affiliated with
-
- Editorial Board
- Manuscript editing services
- Instructions for Editors
- Editors' Profile
- Sign up for article alerts and news from this journal
Follow
Annual Journal Metrics
-
2022 Citation Impact
3.7 - 2-year Impact Factor
3.8 - 5-year Impact Factor
1.040 - SNIP (Source Normalized Impact per Paper)
0.583 - SJR (SCImago Journal Rank)2022 Speed
16 days submission to first editorial decision for all manuscripts (Median)
115 days submission to accept (Median)2022 Usage
493,723 downloads
1,550 Altmetric mentions
What is trending?
Click here to see which articles published in Infectious Agents and Cancer have been shared the most in the past three months.